Analystreport

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $10.00 to $14.00. They now have an "overweight" rating on the stock...

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com